Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling

Cardiovascular Research

Volumn 99, Issue 4, 2013, Pages 665-673

  Wei, Li Hua ^a   Huang, Xiao Ru ^b   Zhang, Yang ^a   Li, You Qi ^b   Chen, Hai Yong ^a   Yan, Bryan P ^a   Yu, Cheuk Man ^a   Lan, Hui Yao ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Ang II; Fibrosis; Inflammation; miR 29; Smad7

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; COLLAGEN TYPE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MICRORNA 29B; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDITIS; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEART DISEASE; HEART EJECTION FRACTION; HEART INJURY; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HYPERTENSION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MICROBUBBLE; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY; UPREGULATION;

ANG II; FIBROSIS; INFLAMMATION; MIR-29; SMAD7;

ANGIOTENSIN II; ANIMALS; FIBROSIS; HYPERTENSION; MALE; MICE; MICRORNAS; MYOCARDIUM; NF-KAPPA B; SMAD7 PROTEIN; SP1 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; VENTRICULAR REMODELING;

EID: 84883239076     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt151     Document Type: Article

References (37)

1. Drazner MH. The progression of hypertensive heart disease. Circulation 2011;123: 327-334.
2. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002;91:988-998.
3. Jia L, LiY, Xiao C,DuJ. Angiotensin II induces inflammation leading to cardiac remodeling. Front Biosci 2012;17:221-231.
4. Shahbaz AU, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC, McGee JE et al. Fibrosis in hypertensive heart disease: molecular pathways and cardioprotective strategies. J Hypertens 2010;28(Suppl. 1):S25-S32.
5. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:C82-C97.
6. Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A et al. NF-kB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 2000; 35:193-201.
7. Rodriguez-Vita J, Sanchez-Lopez E, EstebanV, Ruperez M, Egido J, Ruiz-Ortega M. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation 2005;111:2509-2517.
8. WangW, Huang XR, Canlas E, Oka K, Truong LD, DengCet al. Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ Res 2006;98:1032-1039.
9. KavsakP, Rasmussen RK, Causing CG,Bonni S,ZhuH, ThomsenGHet al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 2000;6:1365-1375.
10. WangW, Huang XR, Li AG, Liu F, Li JH, Truong LD et al. Signaling mechanism of TGF-b1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol 2005;16: 1371-1383.
11. Lan HY. Smad7 as a therapeutic agent for chronic kidney diseases. Front Biosci 2008;13: 4984-4992.
12. Zaman MA, Oparil S, Calhoun DA. Drugs targeting the renin-angiotensin- aldosterone system. Nat Rev Drug Discov 2002;1:621-636.
13. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002;106:130-135.
14. Huang XR, Chung AC, Yang F, YueW, Deng C, Lau CP et al. Smad3 mediates cardiac and fibrosis in angiotensin II-induced hypertensive cardiac remodeling. Hypertension 2010;55: 1165-1171.
15. ChenHY, Huang XR,WangW, Li JH, Heuchel RL, ChungACet al. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential. Diabetes 2011; 60:590-601.
16. ChungAC, Huang XR, Zhou L, Heuchel R, Lai KN, LanHY. Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. Nephrol Dial Transplant 2009;24:1443-1454.
17. Ka SM, Huang XR, Lan HY, Tsai PY, Yang SM, Shui HA et al. Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice. J Am Soc Nephrol 2007;18: 1777-1788.
18. Liu Z, Huang XR, Lan HY. Smad3 mediatesANG II-induced hypertensive kidney disease in mice. Am J Physiol Renal Physiol 2012;302:F986-F997.
19. Lan HY, MuW, Nikolic-Paterson DJ, Atkins RC. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem 1995;43:97-102.
20. QinW, Chung AC, Huang XR, Meng XM, Hui DS, Yu CM et al. TGF-b/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol 2011;22:1462-1474.
21. Motojima M, Ando T, Yoshioka T. Sp1-like activity mediates angiotensin-II-induced plasminogen-activator inhibitor type-1 (PAI-1) gene expression in mesangial cells. Biochem J 2000;349:435-441.
22. Zhao X, Martin MM, Elton TS. The transcription factors Sp1 and Sp3 are required for human angiotensin II type 1 receptor gene expression in H295-R cells. Biochim Biophys Acta 2001;1522:195-206.
23. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, MarshallWSet al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 2008;105:13027-13032.
24. Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J et al. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008;14: 369-381.
25. He X, Gao X, Peng L,Wang S, Zhu Y, Ma H et al. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. Circ Res 2011;108:164-175.
26. Wang B, Hao J, Jones SC, Yee MS, Roth JC, Dixon IM. Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart. Am J Physiol Heart Circ Physiol 2002; 282:H1685-H1696.
27. Yang F, Chung AC, Huang XR, Lan HY. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and-independent Smad pathways: the role of Smad3. Hypertension 2009;54:877-884.
28. Yang F, Huang XR, ChungAC,HouCC, Lai KN, LanHY. Essential role for Smad3 in angiotensin II-induced tubular epithelial-mesenchymal transition. J Pathol 2010;221:390-401.
29. LanHY,MuW, Tomita N, Huang XR, Li JH,ZhuHJ et al. Inhibitionof renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 2003;14:1535-1548.
30. Hou CC, Wang W, Huang XR, Fu P, Chen TH, Sheikh-Hamad D et al. Ultrasoundmicrobubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney. Am J Pathol 2005;166:761-771.
31. Ng YY, Hou CC, Wang W, Huang XR, Lan HY. Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. Kidney Int Suppl 2005;67:S83-S91.
32. Traylor A, Hock T, Hill-Kapturczak N. Specificity protein 1 and Smad-dependent regulation of human heme oxygenase-1 gene by transforming growth factor-beta1 in renal epithelial cells. Am J Physiol Renal Physiol 2007;293:F885-F894.
33. PonceletAC, SchnaperHW. Sp1 and Smad proteins cooperate to mediate transforming growth factor-b1-induced a2(I) collagen expression in human glomerular mesangial cells. J Biol Chem 2001;276:6983-6992.
34. Perkins ND, Agranoff AB, Pascal E, Nabel GJ. An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation. Mol Cell Biol 1994;14:6570-6583.
35. Liu S, Wu LC, Pang J, Santhanam R, Schwind S, Wu YZ et al. Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell 2010;17: 333-347.
36. Xiao J, Meng XM, Huang XR, Chung AC, Feng YL, Hui DS et al. miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol Ther 2012;20:1251-1260.
37. Chung AC, Dong Y, YangW, Zhong X, Li R, Lan HY. Smad7 suppresses renal fibrosis via altering expression of TGF-b/Smad3-regulated microRNAs. Mol Ther 2013;21: 388-398.